Literature DB >> 9361992

Cerebral trauma-induced changes in corpus striatal dopamine receptor subtypes.

J M Henry1, N K Talukder, A B Lee, M L Walker.   

Abstract

A device designed specifically for mild to severe concussions was used to produce quantitative experimental blunt brain injury in male Wistar rats. We have examined the effects of varying magnitudes of cerebral trauma on the maximal binding capacity (Bmax) of D1 and D2 dopamine (DA) receptors. The Bmax for each receptor subtype was obtained from Scatchard analyses of [3H]-SCH 23390 and [3H]Spiperone binding to striatal membrane. Anesthetized rats were injured--one, two, or three times--once every 24 h, with either a 68- or 268-g rubber-headed reflex hammer accelerated from a predetermined distance. Uninjured nonanesthetized (NA) and anesthetized (A) rats served as controls. No significant difference in receptor density was observed between NA and A rats for each receptor subtype. Immediately (0 h) following injury from the 68-g hammer weight, the density of D1 receptors decreased (50%), then increased (30%) above control levels by 24 h. The same pattern was observed with the 268-g hammer weight. Analysis of variance (ANOVA) showed that there was no overall effect of number of injuries or treatment on the density of D1 and D2 receptor subtypes. However, there was an interaction of both variables on the D1, but not D2, receptor subtype. Partial ANOVA for receptor densities after rats were injured either one, two, or three times showed that receptor density was altered only after the rats were injured one time. These results suggest that striatal DA D1 receptors are downregulated and then upregulated following isolated injury to the cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361992     DOI: 10.3109/08941939709032167

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  9 in total

1.  Targeting Dopamine in Acute Traumatic Brain Injury.

Authors:  James W Bales; Anthony E Kline; Amy K Wagner; C Edward Dixon
Journal:  Open Drug Discov J       Date:  2010

Review 2.  Catecholaminergic based therapies for functional recovery after TBI.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Brain Res       Date:  2015-12-19       Impact factor: 3.252

3.  The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (mTBI).

Authors:  Shahaf Edut; Vardit Rubovitch; Shaul Schreiber; Chaim G Pick
Journal:  Psychopharmacology (Berl)       Date:  2010-12-01       Impact factor: 4.530

Review 4.  Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.

Authors:  James W Bales; Amy K Wagner; Anthony E Kline; C Edward Dixon
Journal:  Neurosci Biobehav Rev       Date:  2009-04-01       Impact factor: 8.989

5.  Genetic Variation in the Vesicular Monoamine Transporter: Preliminary Associations With Cognitive Outcomes After Severe Traumatic Brain Injury.

Authors:  Steven M Markos; Michelle D Failla; Anne C Ritter; C Edward Dixon; Yvette P Conley; Joseph H Ricker; Patricia M Arenth; Shannon B Juengst; Amy K Wagner
Journal:  J Head Trauma Rehabil       Date:  2017 Mar/Apr       Impact factor: 2.710

Review 6.  Executive (dys)function after traumatic brain injury: special considerations for behavioral pharmacology.

Authors:  Jenny E Ozga; Jessica M Povroznik; Elizabeth B Engler-Chiurazzi; Cole Vonder Haar
Journal:  Behav Pharmacol       Date:  2018-10       Impact factor: 2.293

7.  Dropped Head Syndrome after Minor Trauma in a Patient with Levosulpiride-Aggravated Vascular Parkinsonism.

Authors:  Soo Hyun Cho; Dokyung Lee; Tae-Beom Ahn
Journal:  J Mov Disord       Date:  2016-03-28

Review 8.  Catecholamines and cognition after traumatic brain injury.

Authors:  Peter O Jenkins; Mitul A Mehta; David J Sharp
Journal:  Brain       Date:  2016-06-02       Impact factor: 13.501

9.  A Systematic Review of Closed Head Injury Models of Mild Traumatic Brain Injury in Mice and Rats.

Authors:  Colleen N Bodnar; Kelly N Roberts; Emma K Higgins; Adam D Bachstetter
Journal:  J Neurotrauma       Date:  2019-03-06       Impact factor: 5.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.